16-fluoroestradiol has been researched along with Carcinoma, Lobular in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Vries, E; Glaudemans, A; Hospers, G; Poppema, B; Schröder, C; Venema, C | 1 |
| Apollonio, G; de Vries, EF; Dierckx, RA; Glaudemans, AW; Hospers, GA; Schröder, CP; Venema, CM | 1 |
| Baird, GS; Kanne, JP; Livingston, RB; Mankoff, DA; Minoshima, S | 1 |
1 review(s) available for 16-fluoroestradiol and Carcinoma, Lobular
| Article | Year |
|---|---|
Recommendations and Technical Aspects of 16α-[18F]Fluoro-17β-Estradiol PET to Image the Estrogen Receptor In Vivo: The Groningen Experience.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Estradiol; Female; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Receptors, Estrogen | 2016 |
2 other study(ies) available for 16-fluoroestradiol and Carcinoma, Lobular
| Article | Year |
|---|---|
18F-FES PET Has Added Value in Staging and Therapy Decision Making in Patients With Disseminated Lobular Breast Cancer.
Topics: Aged; Biopsy; Breast Neoplasms; Carcinoma, Lobular; Decision Making; Estradiol; Female; Humans; Neoplasm Staging; Positron-Emission Tomography | 2017 |
Gastric linitis plastica from metastatic breast carcinoma: FDG and FES PET appearances.
Topics: Aged; Breast Neoplasms; Carcinoma, Lobular; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Linitis Plastica; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2007 |